Point-of-care devices: the next frontier in personalized chemotherapy.
作者信息
Borba Maria Amélia Carlos Souto Maior, Castelletti Carlos Henrique Madeiros, Filho José Luiz de Lima, Martins Danyelly Bruneska Gondim
机构信息
Molecular Prospection & Bioinformatics Group (ProspecMol) - Laboratory of Immunopathology Keizo Asami (LIKA), Federal University of Pernambuco (UFPE), Av. Prof. Moraes Rego 1235, 50670-901, Cidade Universitária, Recife, PE, Brazil.
Agronomic Institute of Pernambuco (IPA), Av. General San Martin 1371, 50761-000, Bongi, Recife, PE, Brazil.
出版信息
Future Sci OA. 2017 Jul 14;3(3):FSO219. doi: 10.4155/fsoa-2017-0059. eCollection 2017 Aug.
Abstract
摘要
相似文献
1
Point-of-care devices: the next frontier in personalized chemotherapy.
Future Sci OA. 2017 Jul 14;3(3):FSO219. doi: 10.4155/fsoa-2017-0059. eCollection 2017 Aug.
2
Digital Phenotyping of Behavioral Symptoms as the Next Frontier for Personalized and Proactive Cancer Care.
JCO Clin Cancer Inform. 2022 Oct;6:e2200095. doi: 10.1200/CCI.22.00095.
3
Digging Deeper into Precision/Personalized Medicine: Cracking the Sugar Code, the Third Alphabet of Life, and Sociomateriality of the Cell.
OMICS. 2020 Feb;24(2):62-80. doi: 10.1089/omi.2019.0220. Epub 2020 Jan 28.
4
The next frontier of clinical trials: personalized medicine for devices.
J Am Coll Cardiol. 2012 Apr 24;59(17):1519-20. doi: 10.1016/j.jacc.2012.01.018. Epub 2012 Mar 7.
5
Perception of Symptoms as the Next Frontier for Personalized Medicine.
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2651-2652. doi: 10.1016/j.jaip.2020.05.035.
6
Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer.
Curr Treat Options Oncol. 2022 Feb;23(2):254-267. doi: 10.1007/s11864-022-00942-8. Epub 2022 Feb 23.
7
Critical Care and Personalized or Precision Medicine: Who needs whom?
J Crit Care. 2018 Feb;43:401-405. doi: 10.1016/j.jcrc.2017.11.026. Epub 2017 Nov 16.
8
Collaborative Paradigm of Preventive, Personalized, and Precision Medicine With Point-of-Care Technologies.
IEEE J Transl Eng Health Med. 2016 Dec 9;4:2800908. doi: 10.1109/JTEHM.2016.2635126. eCollection 2016.
9
Precision medicine in human heart modeling : Perspectives, challenges, and opportunities.
Biomech Model Mechanobiol. 2021 Jun;20(3):803-831. doi: 10.1007/s10237-021-01421-z. Epub 2021 Feb 12.
10
Flipping the Script: Are Cellular Assays and Wound Fluids the Next Frontier in Personalized Wound Care?
J Invest Dermatol. 2025 Mar;145(3):466-468. doi: 10.1016/j.jid.2024.08.007. Epub 2024 Sep 14.
引用本文的文献
1
Portable multi-parametric microscopy for noninvasive metabolic and vascular imaging of orthotopic tongue cancer models .
J Biomed Opt. 2025 Feb;30(Suppl 2):S23905. doi: 10.1117/1.JBO.30.S2.S23905. Epub 2025 Apr 23.
2
Point-of-care optical spectroscopy platform and ratio-metric algorithms for rapid and systematic functional characterization of biological models .
J Biomed Opt. 2024 Dec;29(12):125002. doi: 10.1117/1.JBO.29.12.125002. Epub 2024 Dec 31.
本文引用的文献
1
Recent advances in the design of polymeric microneedles for transdermal drug delivery and biosensing.
Lab Chip. 2017 Apr 11;17(8):1373-1387. doi: 10.1039/c7lc00016b.
2
Smartphone-based enzymatic biosensor for oral fluid L-lactate detection in one minute using confined multilayer paper reflectometry.
Biosens Bioelectron. 2017 Aug 15;94:124-130. doi: 10.1016/j.bios.2017.02.053. Epub 2017 Mar 1.
3
Point of care testing: The impact of nanotechnology.
Biosens Bioelectron. 2017 Jan 15;87:373-387. doi: 10.1016/j.bios.2016.08.084. Epub 2016 Aug 26.
4
Evaluating the impact of missenses mutations in CYP2D6*7 and CYP2D6*14A: does it compromise tamoxifen metabolism?
Pharmacogenomics. 2016 Apr;17(6):573-82. doi: 10.2217/pgs-2015-0003. Epub 2016 Apr 4.
5
Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use.
Oncotarget. 2016 Apr 26;7(17):24252-68. doi: 10.18632/oncotarget.8132.
6
Chemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastoma.
Anal Cell Pathol (Amst). 2015;2015:150634. doi: 10.1155/2015/150634. Epub 2015 Jul 14.
7
Personalized medicine: Time for one-person trials.
Nature. 2015 Apr 30;520(7549):609-11. doi: 10.1038/520609a.
8
Molecular mechanisms of drug resistance and its reversal in cancer.
Crit Rev Biotechnol. 2016 Aug;36(4):716-26. doi: 10.3109/07388551.2015.1015957. Epub 2015 Mar 11.
9
Pharmacogenetics and breast cancer management: current status and perspectives.
Expert Opin Drug Metab Toxicol. 2015 May;11(5):719-29. doi: 10.1517/17425255.2015.1008447. Epub 2015 Feb 18.
10
Biomarkers for personalized oncology: recent advances and future challenges.
Metabolism. 2015 Mar;64(3 Suppl 1):S16-21. doi: 10.1016/j.metabol.2014.10.027. Epub 2014 Oct 30.
Zotero 插件